IGC Pharma changes fiscal year-end from March 31 to December 31, effective 2025

IGC Pharma, Inc.

Board approved fiscal year change from March 31 to December 31, effective Dec 31, 2025.
Company will file a Transition Report on Form 10-K for the nine-month period April 1 to Dec 31, 2025.
Future fiscal years will end on December 31, aligning with the calendar year.

item 5.03

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

IGC Pharma, Inc.: Changed fiscal year-end from March 31 to December 31 (effective 2025-12-31).

Change: fiscal year change
Effective: 2025-12-31

Exact text from the filing

the Board of Directors (the “Board”) of IGC Pharma, Inc. (the “Company”) approved a change in the Company’s fiscal year-end from March 31 to December 31. The fiscal year change will be effective on December 31, 2025.

View on SEC.gov

Browse all governance changes →

IGC Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001185185-26-000010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.